Search Results - "CIOFETTA, M"
-
1
Long-term intensive treatment of type 1 diabetes with the short-acting insulin analog lispro in variable combination with NPH insulin at mealtime
Published in Diabetes care (01-03-1999)“…Long-term intensive treatment of type 1 diabetes with the short-acting insulin analog lispro in variable combination with NPH insulin at mealtime. C Lalli , M…”
Get full text
Journal Article -
2
Meticulous prevention of hypoglycemia normalizes the glycemic thresholds and magnitude of most of neuroendocrine responses to, symptoms of, and cognitive function during hypoglycemia in intensively treated patients with short-term IDDM
Published in Diabetes (New York, N.Y.) (01-11-1993)“…Meticulous prevention of hypoglycemia normalizes the glycemic thresholds and magnitude of most of neuroendocrine responses to, symptoms of, and cognitive…”
Get full text
Journal Article -
3
Long-term recovery from unawareness, deficient counterregulation and lack of cognitive dysfunction during hypoglycaemia, following institution of rational, intensive insulin therapy in IDDM
Published in Diabetologia (01-12-1994)“…Hypoglycaemia unawareness, is a major risk factor for severe hypoglycaemia and a contraindication to the therapeutic goal of near-normoglycaemia in IDDM. We…”
Get full text
Journal Article -
4
Use of the short-acting insulin analogue lispro in intensive treatment of Type 1 diabetes mellitus: importance of appropriate replacement of basal insulin and time-interval injection-meal
Published in Diabetic medicine (01-07-1998)“…To establish whether lispro may be a suitable short‐acting insulin preparation for meals in intensive treatment of Type 1 diabetes mellitus (DM) in patients…”
Get full text
Journal Article -
5
Contribution of autonomic neuropathy to reduced plasma adrenaline responses to hypoglycemia in IDDM: evidence for a nonselective defect
Published in Diabetes (New York, N.Y.) (01-05-1997)“…Contribution of autonomic neuropathy to reduced plasma adrenaline responses to hypoglycemia in IDDM: evidence for a nonselective defect. P Bottini , E…”
Get full text
Journal Article -
6
Evidence of increased systemic glucose production and gluconeogenesis in an early stage of NIDDM
Published in Diabetes (New York, N.Y.) (01-06-1997)“…Evidence of increased systemic glucose production and gluconeogenesis in an early stage of NIDDM. G Perriello , S Pampanelli , P Del Sindaco , C Lalli , M…”
Get full text
Journal Article -
7
Relative roles of insulin and hypoglycaemia on induction of neuroendocrine responses to, symptoms of, and deterioration of cognitive function in hypoglycaemia in male and female humans
Published in Diabetologia (01-08-1994)“…To assess the relative roles of insulin and hypoglycaemia on induction of neuroendocrine responses, symptoms and deterioration of cognitive function (12…”
Get full text
Journal Article -
8
Pharmacokinetics, pharmacodynamics and glucose counterregulation following subcutaneous injection of the monomeric insulin analogue [Lys(B28),Pro(B29)] in IDDM
Published in Diabetologia (01-07-1994)“…The aim of these studies was to compare the pharmacokinetics, pharmacodynamics, counterregulatory hormone and symptom responses, as well as cognitive function…”
Get full text
Journal Article -
9
Long-term intensive therapy of IDDM patients with clinically overt autonomic neuropathy: effects on hypoglycemia awareness and counterregulation
Published in Diabetes (New York, N.Y.) (01-07-1997)“…Long-term intensive therapy of IDDM patients with clinically overt autonomic neuropathy: effects on hypoglycemia awareness and counterregulation. C Fanelli , S…”
Get full text
Journal Article -
10
Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function
Published in Diabetes care (01-11-1995)“…Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic…”
Get full text
Journal Article -
11
Long-term intensive insulin therapy in IDDM : effects of HbA1c, risk for severe and mild hypoglycaemia, status of counterregulation and awareness of hypoglycaemia
Published in Diabetologia (01-06-1996)“…The present studies were designed to assess the percentage of HbA1c, frequency, and awareness of hypoglycaemia (H) during long-term intensive therapy (IT) of…”
Get full text
Journal Article -
12
Contribution of postprandial versus interprandial blood glucose to HbA1c in type 1 diabetes on physiologic intensive therapy with lispro insulin at mealtime
Published in Diabetes care (01-05-1999)“…Contribution of postprandial versus interprandial blood glucose to HbA1c in type 1 diabetes on physiologic intensive therapy with lispro insulin at mealtime. M…”
Get full text
Journal Article -
13
Acute, short-term hyperglycemia enhances shear stress-induced platelet activation in patients with type II diabetes mellitus
Published in Journal of the American College of Cardiology (19-03-2003)“…The aim of our study was to assess whether acute, short-term hyperglycemia affects platelet reactivity in patients with Type II diabetes mellitus (T2DM)…”
Get full text
Journal Article -
14
Post-hypoglycaemic hyperketonaemia does not contribute to brain metabolism during insulin-induced hypoglycaemia in humans
Published in Diabetologia (01-11-1993)“…It is controversial as to whether ketone bodies are utilized by the human brain as a fuel alternative to glucose during hypoglycaemia. To clarify the issue, we…”
Get full text
Journal Article -
15
Meticulous prevention of hypoglycemia normalizes the glycemic thresholds and magnitude of most of neuroendocrine responses to, symptoms of, and cognitive function during hypoglycemia in intensively treated patients with short-term IDDM
Published in Diabetes (New York, N.Y.) (01-11-1993)“…To test the hypothesis that hypoglycemia unawareness is largely secondary to recurrent therapeutic hypoglycemia in IDDM, we assessed neuroendocrine and symptom…”
Get full text
Journal Article -
16
Evidence of increased systemic glucose production and gluconeogenesis in an early stage of NIDDM
Published in Diabetes (New York, N.Y.) (01-06-1997)“…To assess the mechanisms of fasting hyperglycemia in NIDDM patients with mild elevation of fasting plasma glucose (FPG) compared with NIDDM patients with overt…”
Get full text
Journal Article -
17
Long-term intensive therapy of IDDM patients with clinically overt autonomic neuropathy: Effects on hypoglycemia awareness and counterregulation
Published in Diabetes (New York, N.Y.) (01-07-1997)“…To test the hypothesis that hypoglycemia unawareness and impaired counterregulation are reversible after meticulous prevention of hypoglycemia in IDDM patients…”
Get full text
Journal Article -
18
-
19
Contribution of autonomic neuropathy to reduced plasma adrenaline responses to hypoglycemia in IDDM evidence for a nonselective defect
Published in Diabetes (New York, N.Y.) (01-05-1997)“…To determine the contribution of clinically overt diabetic autonomic neuropathy (DAN) to reduced plasma adrenaline responses to hypoglycemia in IDDM and to…”
Get full text
Journal Article -
20